ArticleOncotarget2014

Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma.

Ming-Huang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.